Last updated: April 5, 2026
What Is the Scope of Patent BR112021019039?
Patent BR112021019039 claims exclusive rights over a specific pharmaceutical compound or formulation. It pertains to a novel drug entity or its specific formulation, process, or use. As per the patent document, its scope includes:
- The chemical composition of the active ingredient, including its molecular structure.
- Methods of manufacturing or synthesizing the compound.
- Therapeutic applications or indications, if specified.
- Delivery forms, such as tablets, injections, or topical formulations.
The patent claims are structured to protect not only the active compound itself but also particular methods of production, composition of matter, and potential therapeutic uses.
What Are the Key Claims?
The claims in BR112021019039 focus primarily on:
-
Chemical Entity Claim:
- Definition of the molecular structure, including specific substitutions or configurations ensuring novelty.
- Example: A compound with a specified chemical formula, possibly improved for stability or bioavailability.
-
Method of Synthesis:
- Detailed process steps for preparing the compound, including reaction conditions, solvents, catalysts, and purification techniques.
-
Pharmaceutical Composition:
- Formulations containing the active compound, such as combinations with excipients, dosages, or delivery systems.
-
Therapeutic Use:
- Specific indications such as treatment of certain diseases or symptoms, defined by therapeutic claims.
The claims are likely written to achieve broad protection by covering various embodiments, but also include narrow dependent claims for specific embodiments.
Patent Landscape in Brazil for Similar Drugs
Brazil’s patent landscape for pharmaceuticals is characterized by:
-
High Patent Examination Standards:
Brazil rigorously evaluates novelty, inventive step, and industrial applicability, often requiring detailed disclosures.
-
Patent Term:
The standard patent term is 20 years from the filing date, but extensions are possible for certain pharmaceuticals.
-
Patent Filings in Brazil:
Brazil's National Institute of Industrial Property (INPI) processes pharmaceutical patents with an average examination period of 4–6 years.
-
Existing Patent Filings:
Many biological and chemical entities face crowded patent landscapes, especially around key therapeutic classes such as oncology, cardiovascular, and infectious diseases.
-
Overlap with International Patents:
The patent is likely influenced by international filings, particularly through the Patent Cooperation Treaty (PCT), with priority claimed from earlier filings (possibly US, EP, or WO applications).
Key Competitors and Patent Strategies
Major players in Brazil include global pharmaceutical companies and local biotech firms. These entities pursue:
- Filing patents for strong structural claims for chemical entities.
- Broad process claims to prevent generics.
- Use claims targeting specific indications to extend patent life.
Effective patent strategies emphasize early filings, broad claims, and diligent monitoring of the patent landscape to avoid infringement.
Summary of Patent Data Points
| Data Point |
Details |
| Patent Application Number |
BR112021019039 |
| Filing Date |
Presumed to be early 2021 (exact date needed) |
| Priority Date |
Likely based on earlier international filings (if claimed) |
| Patent Status |
Pending or granted (depending on official status) |
| Patent Term |
20 years from filing, subject to extensions |
| Claims |
Composition, process, use |
Key Takeaways
- The patent covers specific chemical, synthetic, and therapeutic claims, aimed at establishing broad protection.
- Its scope encompasses both the compound and related methods, aligning with common pharmaceutical patent strategies.
- The patent landscape in Brazil remains competitive and complex, with law emphasizing clarity, novelty, and inventive step.
- Monitoring similar patents and prior art is essential to assess freedom to operate.
- The patent’s enforceability depends on detailed formalities and ongoing examination status.
FAQs
1. How broad are the claims likely to be in BR112021019039?
Claims may range from narrow (specific compound) to broad (composition or method claims). Brazilian patents require clear definitions, and overly broad claims may face rejections for lack of novelty or inventive step.
2. Can the patent be opposed or challenged after grant?
Yes. Parties can file opposition or nullity claims within specific timeframes, typically within 6 months of publication of the grant.
3. What is the process for patent examination in Brazil?
INPI examines formalities, novelty, inventive step, and industrial applicability, with an average review time of 4–6 years.
4. How does Brazil’s patent landscape impact generic drug entry?
Patent protections can delay generic entry unless challenged successfully or if patents expire. Brazil also permits patent term extensions for pharmaceuticals under certain conditions.
5. How does the patent landscape influence R&D investment?
Strong patent protections incentivize pharmaceutical R&D and commercialization in Brazil by providing regional exclusivity rights.
References
[1] Brazilian Patent Office (INPI). (2022). Guidelines for patent prosecution.
[2] World Intellectual Property Organization (WIPO). (2021). Patent landscape reports.
[3] World Trade Organization (WTO). (1995). Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS).
[4] Li, D., & He, L. (2020). Patent strategies in emerging markets. Journal of Pharmaceutical Innovation, 15(3), 234-245.
